Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Risk of autoimmune complications associated with interferon therapy.

Literature DB >> 23293568

Risk of autoimmune complications associated with interferon therapy.

Marcelo O Silva¹.

Abstract

Entities: Disease

Year: 2012 PMID： 23293568 PMCID： PMC3533213

Source DB: PubMed Journal: Gastroenterol Hepatol (N Y) ISSN： 1554-7914

× No keyword cloud information.

8 in total

Review 1. The management of side-effects during therapy for hepatitis C.

Authors: R J Aspinall; P J Pockros
Journal: Aliment Pharmacol Ther Date: 2004-11-01 Impact factor: 8.171

2. Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy.

Authors: Luis Jesuino de Oliveira Andrade; Ajax Mercês Atta; Maria Luiza Brito de Sousa Atta; Célia Neder Kalil Mangabeira; Raymundo Paraná
Journal: Braz J Infect Dis Date: 2011 Jul-Aug Impact factor: 1.949

3. De novo autoimmune hepatitis subsequent to switching from type 2b to type 2a alpha-pegylated interferon treatment for recurrent hepatitis C after liver transplantation: report of a case.

Authors: Kazuki Takeishi; Ken Shirabe; Takeo Toshima; Toru Ikegami; Kazutoyo Morita; Takasuke Fukuhara; Takashi Motomura; Yohei Mano; Hideaki Uchiyama; Yuji Soejima; Akinobu Taketomi; Yoshihiko Maehara
Journal: Surg Today Date: 2011-07-12 Impact factor: 2.549

Review 4. Environmental triggers of thyroiditis: hepatitis C and interferon-α.

Authors: F Menconi; A Hasham; Y Tomer
Journal: J Endocrinol Invest Date: 2010-02-28 Impact factor: 4.256

5. A meta-analysis of patients with chronic hepatitis C treated with interferon-alpha to determine the risk of autoimmune thyroiditis.

Authors: Luis Jesuino de Oliveira Andrade; Argemiro D'Oliveira; Carolina Alves Costa Silva; Paulo Nunes; Larissa Santos França; Ana Micheline Andrade Malta; Raymundo Paraná
Journal: Acta Gastroenterol Latinoam Date: 2011-06

6. A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon.

Authors: G Fattovich; G Giustina; S Favarato; A Ruol
Journal: J Hepatol Date: 1996-01 Impact factor: 25.083

7. Interferon-induced chronic active hepatitis?

Authors: M O Silva; K R Reddy; L J Jeffers; M Hill; E R Schiff
Journal: Gastroenterology Date: 1991-09 Impact factor: 22.682

Review 8. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection.

Authors: Leslie E Wilson; David Widman; Steven H Dikman; Peter D Gorevic
Journal: Semin Arthritis Rheum Date: 2002-12 Impact factor: 5.532

8 in total

5 in total

1. GPIHBP1 autoantibody syndrome during interferon β1a treatment.

Authors: Jun Eguchi; Kazuya Miyashita; Isamu Fukamachi; Katsuyuki Nakajima; Masami Murakami; Yuko Kawahara; Toru Yamashita; Yasuyuki Ohta; Koji Abe; Atsuko Nakatsuka; Mai Mino; Satoru Takase; Hiroaki Okazaki; Robert A Hegele; Michael Ploug; Xuchen Hu; Jun Wada; Stephen G Young; Anne P Beigneux
Journal: J Clin Lipidol Date: 2018-10-24 Impact factor: 4.766

Review 2. Chylomicronemia from GPIHBP1 autoantibodies.

Authors: Kazuya Miyashita; Jens Lutz; Lisa C Hudgins; Dana Toib; Ambika P Ashraf; Wenxin Song; Masami Murakami; Katsuyuki Nakajima; Michael Ploug; Loren G Fong; Stephen G Young; Anne P Beigneux
Journal: J Lipid Res Date: 2020-09-18 Impact factor: 5.922